AMG 837 hemicalcium salt
Cat. No. 6082
Chemical Name: (βS)-β-1-Propyn-1-yl-4-[[4'-(trifluoro
Biological ActivityPotent free fatty acid receptor 1 (FFA1/GPR40) partial agonist (EC50 values are 13.5, 22.6 and 31.7 nM at human, mouse and rat receptors, respectively). Interacts allosterically with full FFA1 agonist Docosahexaenoic acid (Cat. No. 3687). Potentiates glucose-dependent stimulation of insulin in vivo. Antidiabetic.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Houze et al (2012) AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorg.Med.Chem.Lett. 22 1267. PMID: 22217876.
Lin et al (2012) Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor. Mol.Pharmacol. 82 843. PMID: 22859723.
Lin et al (2011) AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents. PLoS One 6 e27270. PMID: 22087278.
If you know of a relevant reference for AMG 837 hemicalcium salt please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses AMG 837 hemicalcium salt from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: AMG 837 hemicalcium salt, supplier, AMG837, hemicalcium, salt, Potent, free, fatty, acid, receptors, 1, FFA1, GPR40, partial, agonists, allosteric, modulator, antidiabetic, insulin, agonism, type, 2, diabetes, orally, bioavailable, Tocris Bioscience, Free Fatty Acid Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Highly potent P2Y12 antagonistFTY 720
Potent S1P receptor agonist; also immunosuppressantCinacalcet hydrochloride
Calcium-sensing receptor (CaSR) allosteric agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailableUMB 68
GHB receptor ligandAZD 1283
High affinity P2Y12 antagonistEx 26
Potent and selective S1P1 receptor antagonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.